Proponents of physical punishment often cite historical experiments to justify the practice. However, a new analysis ...
MedPage Today on MSN
Cannabinoids for Mental, Substance Use Disorders 'Rarely Justified,' Study Suggests
Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...
Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for left bundle branch block in heart failure.
Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
OSTEOPATHIC manipulative treatment (OMT) may improve pulmonary function in asthma, though current evidence remains limited ...
In A Nutshell Among older adults carrying the APOE ε4 gene variant, the predominant genetic risk factor for Alzheimer’s ...
This study evaluates a new fecal microbiota transplant method, revealing significant symptom improvements in children with ...
BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart ...
Elevated blood pressure (hypertension) is a leading, preventable risk factor for heart disease. Nicotinamide mononucleotide ...
Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...
A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results